PALB2 sequencing in Italian familial breast cancer cases reveals a high-risk mutation recurrent in the province of Bergamo

The incidence of PALB2 c.3113G>A in women with a strong family history of breast and ovarian cancer attending familial cancer centres in Australia

(2013) Zhi L. Teo et al.   Familial Cancer

Large-scale genotyping identifies 41 new loci associated with breast cancer risk

(2013) Kyriaki Michailidou et al.   NATURE GENETICS

Whole Exome Sequencing Suggests Much of Non-BRCA1/BRCA2 Familial Breast Cancer Is Due to Moderate and Low Penetrance Susceptibility Alleles

(2013) Francisco Javier Gracia-Aznarez et al.   PLoS One

Comparative In Vitro and In Silico Analyses of Variants in Splicing Regions of BRCA1 and BRCA2 Genes and Characterization of Novel Pathogenic Mutations

(2013) Mara Colombo et al.   PLoS One

Assessment of SLX4 Mutations in Hereditary Breast Cancers

(2013) Sohela Shah et al.   PLoS One

Prevalence of PALB2 Mutations in Breast Cancer Patients in Multi-Ethnic Asian Population in Malaysia and Singapore

(2013) Sze Yee Phuah et al.   PLoS One

Rare Mutations in XRCC2 Increase the Risk of Breast Cancer

(2012) D.J. Park et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Analysis of SLX4/FANCP in non-BRCA1/2-mutated breast cancer families

(2012) Juana Fernández-Rodríguez et al.   BMC CANCER

Low prevalence of SLX4 loss-of-function mutations in non-BRCA1/2 breast and/or ovarian cancer families

(2012) Gorka Ruiz de Garibay et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families

(2012) Irene Catucci et al.   Familial Cancer

Analysis of the Novel Fanconi Anemia GeneSLX4/FANCPin Familial Breast Cancer Cases

(2012) Janine L. Bakker et al.   HUMAN MUTATION

Rare germline mutations inPALB2and breast cancer risk: A population-based study

(2012) Marc Tischkowitz et al.   HUMAN MUTATION

Rare variants in XRCC2 as breast cancer susceptibility alleles: Table 1

(2012) Florentine S Hilbers et al.   JOURNAL OF MEDICAL GENETICS

Germline RAD51C mutations confer susceptibility to ovarian cancer

(2012) Chey Loveday et al.   NATURE GENETICS

Sequencing Analysis of SLX4/FANCP Gene in Italian Familial Breast Cancer Cases

(2012) Irene Catucci et al.   PLoS One

Mutation Analysis of BRCA1, BRCA2, PALB2 and BRD7 in a Hospital-Based Series of German Patients with Triple-Negative Breast Cancer

(2012) Franziska Pern et al.   PLoS One

Mutation analysis of the SLX4/FANCP gene in hereditary breast cancer

(2011) Rosa Landwehr et al.   BREAST CANCER RESEARCH AND TREATMENT

Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer

(2011) Ana Blanco et al.   BREAST CANCER RESEARCH AND TREATMENT

Contribution of Inherited Mutations in the BRCA2-Interacting Protein PALB2 to Familial Breast Cancer

(2011) S. Casadei et al.   CANCER RESEARCH

Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer

(2011) Heide Hellebrand et al.   HUMAN MUTATION

A novel germline PALB2 deletion in Polish breast and ovarian cancer patients

(2010) Agnieszka Dansonka-Mieszkowska et al.   BMC Medical Genetics

PALB2 germline mutations in familial breast cancer cases with personal and family history of pancreatic cancer

(2010) Paolo Peterlongo et al.   BREAST CANCER RESEARCH AND TREATMENT

Genetic susceptibility to breast cancer

(2010) Nasim Mavaddat et al.   Molecular Oncology

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

(2010) Alfons Meindl et al.   NATURE GENETICS

The Breast Cancer Susceptibility Mutation PALB2 1592delT Is Associated with an Aggressive Tumor Phenotype

(2009) T. Heikkinen et al.   CLINICAL CANCER RESEARCH

The contribution of founder mutations to early-onset breast cancer in French-Canadian women

(2009) P Ghadirian et al.   CLINICAL GENETICS

Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families

(2008) María J. García et al.   BREAST CANCER RESEARCH AND TREATMENT